It was found that of the 50 confirmed expressed non-synonymous mutations, one-third of these mutated epitopes were as strongly immunogenic as the positive control TRP-2 which is the strongest known B16.F10 murine melanoma antigen. The gene discussed is DCT; the disease is melanoma.